Optimization of 18F‐syntheses using 19F‐reagents at tracer‐level concentrations and liquid chromatography/tandem mass spectrometry analysis: Improved synthesis of [18F]MDL100907
- 17 April 2018
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 61 (5) , 427-437
Abstract
Traditional radiosynthetic optimization faces the challenges of high radiation exposure, cost, and inability to perform serial reactions due to tracer decay. To accelerate tracer development, we have developed a strategy to simulate radioactive 18F‐syntheses by using tracer‐level (nanomolar) non‐radioactive 19F‐reagents and LC‐MS/MS analysis. The methodology was validated with fallypride synthesis under tracer‐level 19F‐conditions, which showed reproducible and comparable results with radiosynthesis, and proved the feasibility of this process. Using this approach, the synthesis of [18F]MDL100907 was optimized under 19F‐conditions with greatly improved yield. The best conditions were successfully transferred to radiosynthesis. A radiochemical yield of 19% to 22% was achieved with the radiochemical purity >99% and the molar activity 38.8 to 53.6 GBq/ μmol (n = 3). The tracer‐level 19F‐approach provides a high‐throughput and cost‐effective process to optimize radiosynthesis with reduced radiation exposure. This new method allows medicinal and synthetic chemists to optimize radiolabeling conditions without the need to use radioactivity.Keywords
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 29 references indexed in Scilit:
- Metabolite identification and quantitation in LC-MS/MS-based metabolomicsTrAC Trends in Analytical Chemistry, 2012
- The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imagingNeuroImage, 2009
- Synthesis of the positron-emitting radiotracer [18F]-2-fluoro-2-deoxy-d-glucose from resin-bound perfluoroalkylsulfonatesOrganic & Biomolecular Chemistry, 2008
- Synthesis, radiofluorination and first evaluation of (±)‐[18F]MDL 100907 as serotonin 5‐HT2A receptor antagonist for PETJournal of Labelled Compounds and Radiopharmaceuticals, 2008
- Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small moleculesJournal of Fluorine Chemistry, 2006
- Recent advances (1995–2005) in fluorinated pharmaceuticals based on natural productsJournal of Fluorine Chemistry, 2006
- Molecular Imaging: Looking at Problems, Seeing SolutionsScience, 2003
- Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracerNuclear Medicine and Biology, 1995
- Direct displacement with anhydrous fluoride of the C-2 trifluoromethanesulphonate of methyl 4,6-O-benzylidene-3-O-methyl-2-O-trifluoromethylsulphonyl-β- D -mannopyranosideJournal of the Chemical Society, Chemical Communications, 1982
- Mass spectrometric determination of picomole amounts of prostaglandins E2 and F2α using synthetic deuterium labeled carriersBiochemical and Biophysical Research Communications, 1971